| Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression NR Wray, S Ripke, M Mattheisen, M Trzaskowski, EM Byrne, A Abdellaoui, ... Nature genetics 50 (5), 668-681, 2018 | 2780 | 2018 |
| Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits A Caspi, AR Hariri, A Holmes, R Uher, TE Moffitt American journal of Psychiatry 167 (5), 509-527, 2010 | 1766 | 2010 |
| Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis V Nanni, R Uher, A Danese American Journal of Psychiatry 169 (2), 141-151, 2012 | 1713 | 2012 |
| A mega-analysis of genome-wide association studies for major depressive disorder Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium Molecular psychiatry 18 (4), 10.1038/mp. 2012.21, 2012 | 1282 | 2012 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological … SH Kennedy, RW Lam, RS McIntyre, SV Tourjman, V Bhat, P Blier, ... The Canadian Journal of Psychiatry 61 (9), 540-560, 2016 | 1227 | 2016 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1149 | 2019 |
| Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies D Rasic, T Hajek, M Alda, R Uher Schizophrenia bulletin 40 (1), 28-38, 2014 | 857 | 2014 |
| Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines A Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, ... Journal of Psychopharmacology 29 (5), 459-525, 2015 | 733 | 2015 |
| Rare and low-frequency coding variants alter human adult height E Marouli, M Graff, C Medina-Gomez, KS Lo, AR Wood, TR Kjaer, RS Fine, ... Nature 542 (7640), 186-190, 2017 | 678 | 2017 |
| The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis R Uher, P McGuffin Molecular psychiatry 13 (2), 131-146, 2008 | 642 | 2008 |
| Time for united action on depression: a Lancet–World Psychiatric Association Commission H Herrman, V Patel, C Kieling, M Berk, C Buchweitz, P Cuijpers, ... The Lancet 399 (10328), 957-1022, 2022 | 602 | 2022 |
| Medial prefrontal cortex activity associated with symptom provocation in eating disorders R Uher, T Murphy, MJ Brammer, T Dalgleish, ML Phillips, VW Ng, ... American Journal of Psychiatry 161 (7), 1238-1246, 2004 | 591 | 2004 |
| Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study KW Choi, CY Chen, MB Stein, YC Klimentidis, MJ Wang, KC Koenen, ... JAMA psychiatry 76 (4), 399-408, 2019 | 588 | 2019 |
| The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update R Uher, P McGuffin Molecular psychiatry 15 (1), 18-22, 2010 | 551 | 2010 |
| Major depressive disorder in DSM‐5: Implications for clinical practice and research of changes from DSM‐IV R Uher, JL Payne, B Pavlova, RH Perlis Depression and anxiety 31 (6), 459-471, 2014 | 544 | 2014 |
| Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’ A Cattaneo, M Gennarelli, R Uher, G Breen, A Farmer, KJ Aitchison, ... Neuropsychopharmacology 38 (3), 377-385, 2013 | 494 | 2013 |
| The contribution of prenatal and postnatal maternal anxiety and depression to child maladjustment ED Barker, SR Jaffee, R Uher, B Maughan Depression and anxiety 28 (8), 696-702, 2011 | 450 | 2011 |
| An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline R Uher, KE Tansey, T Dew, W Maier, O Mors, J Hauser, MZ Dernovsek, ... American Journal of Psychiatry 171 (12), 1278-1286, 2014 | 444 | 2014 |
| Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms R Uher, RH Perlis, N Henigsberg, A Zobel, M Rietschel, O Mors, J Hauser, ... Psychological medicine 42 (5), 967-980, 2012 | 438 | 2012 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments SV Parikh, LC Quilty, P Ravitz, M Rosenbluth, B Pavlova, S Grigoriadis, ... The Canadian Journal of Psychiatry 61 (9), 524-539, 2016 | 403 | 2016 |
Peter McGuffinEmeritus Professor of Psychiatric Genetics, King's College LondonEmail verificata su kcl.ac.uk